National surveillance using a clinical quality indicator for prolonged antipsychotic use among older Australians with dementia who access aged care services

被引:3
作者
Sluggett, Janet K. [1 ,2 ]
Caughey, Gillian E. [1 ,2 ]
Air, Tracy [2 ]
Cations, Monica [2 ,3 ]
Lang, Catherine E. [2 ]
Ward, Stephanie A. [4 ,5 ,6 ]
Ahern, Susannah [6 ]
Lin, Xiaoping [6 ]
Wallis, Kasey [6 ]
Crotty, Maria [7 ,8 ]
Inacio, Maria C. [1 ,2 ]
机构
[1] Univ South Australia, UniSA Allied Hlth & Human Performance, GPO Box 2471, Adelaide, SA, Australia
[2] South Australian Hlth & Med Res Inst, Registry Sr Australians ROSA, Adelaide, SA, Australia
[3] Flinders Univ S Australia, Coll Educ Psychol & Social Work, Adelaide, SA, Australia
[4] Univ New South Wales, Ctr Hlth Brain Ageing, Sch Psychiat, Sydney, NSW, Australia
[5] Prince Wales Hosp, Dept Geriatr Med, Randwick, NSW 2031, Australia
[6] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia
[7] Southern Adelaide Local Hlth Network, SA Hlth, Adelaide, SA, Australia
[8] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
antipsychotic agents; Australia; dementia; drug utilization; health care; home care services; long-term care; medication adherence; nursing homes; quality indicators; ALZHEIMERS-DISEASE; PREVALENCE; FRACTURE; RISK;
D O I
10.1002/gps.6089
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: Dementia guidelines recommend antipsychotics are only used for behavioral and psychological symptoms when non-drug interventions fail, and to regularly review use. Population-level clinical quality indicators (CQIs) for dementia care in permanent residential aged care (PRAC) typically monitor prevalence of antipsychotic use but not prolonged use. This study aimed to develop a CQI for antipsychotic use >90 days and examine trends, associated factors, and variation in CQI incidence; and examine duration of the first episode of use among individuals with dementia accessing home care packages (HCPs) or PRAC. Methods: Retrospective cohort study, including older individuals with dementia who accessed HCPs (n = 50,257) or PRAC (n = 250,196). Trends in annual CQI incidence (2011-12 to 2015-16) and associated factors were determined using Poisson regression. Funnel plots examined geographical and facility variation. Time to antipsychotic discontinuation was estimated among new antipsychotic users accessing HCP (n = 2367) and PRAC (n = 15,597) using the cumulative incidence function. Results: Between 2011-12 and 2015-16, antipsychotic use for >90 days decreased in HCP recipients from 10.7% (95% CI 10.2-11.1) to 10.1% (95% CI 9.6-10.5, adjusted incidence rate ratio (aIRR) 0.97 (95% CI 0.95-0.98)), and in PRAC residents from 24.5% (95% CI 24.2-24.7) to 21.8% (95% CI 21.5-22.0, aIRR 0.97 (95% CI 0.96-0.98)). Prior antipsychotic use (both cohorts) and being male and greater socioeconomic disadvantage (PRAC cohort) were associated with higher CQI incidence. Little geographical/facility variation was observed. Median treatment duration in HCP and PRAC was 334 (interquartile range [IQR] 108-958) and 555 (IQR 197-1239) days, respectively. Conclusions: While small decreases in antipsychotic use >90 days were observed between 2011-12 and 2015-16, findings suggest antipsychotic use among aged care recipients with dementia can be further minimized.
引用
收藏
页数:11
相关论文
共 62 条
[31]   Duration of Antipsychotic Medication Use by Aged Care Facility Residents With Dementia [J].
Lind, Kimberly E. ;
Raban, Magdalena Z. ;
Georgiou, Andrew ;
Westbrook, Johanna, I .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2019, 33 (04) :331-338
[32]   Prevalence and persistent use of psychotropic drugs in older adults receiving domiciliary care at baseline [J].
Lornstad, Marie Turmo ;
Aaroen, Marte ;
Bergh, Sverre ;
Benth, Jurate Saltyte ;
Helvik, Anne-Sofie .
BMC GERIATRICS, 2019, 19 (1)
[33]   Prevalence of Psychotropic and Opioid Prescription Fills Among Community-Dwelling Older Adults With Dementia in the US [J].
Maust, Donovan T. ;
Strominger, Julie ;
Bynum, Julie P. W. ;
Langa, Kenneth M. ;
Gerlach, Lauren B. ;
Zivin, Kara ;
Marcus, Steven C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (07) :706-+
[34]   Impact of the Covid-19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings [J].
McDermid, Joanne ;
Ballard, Clive ;
Khan, Zunera ;
Aarsland, Dag ;
Fox, Chris ;
Fossey, Jane ;
Clare, Linda ;
Moniz-Cook, Esme ;
Soto-Martin, Maria ;
Sweetnam, Adrienne ;
Mills, Kathryn ;
Cummings, Jeffrey ;
Corbett, Anne .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2023, 38 (01)
[35]  
MedicineWise NPS., 2022, Reviewing and Tapering Antipsychotic Medicines for BPSD
[36]   What Makes Deprescription of Psychotropic Drugs in Nursing Home Residents with Dementia so Challenging? A Qualitative Systematic Review of Barriers and Facilitators [J].
Moth, Amalie Elisabeth ;
Holmkjaer, Pernille ;
Holm, Anne ;
Rozing, Maarten Pieter ;
Overbeck, Gritt .
DRUGS & AGING, 2021, 38 (08) :671-685
[37]  
Nolte E., 2014, International Variation in Drug Usage: An exploratory analysis of the "causes"of variation
[38]  
NSW Therapeutic Advisory Group, 2021, Deprescribing Tools Australia
[39]  
Peisah C., 2014, The use of restraints psychotropic medications in people with dementia
[40]  
Pharmaceutical Society of Australia, 2020, Medicine Safety Forum: Informing Australias 10th National Health Priorty Area